UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A concise explanation of blockchain terms, covering distributed ledgers, immutability, and consensus, to help readers grasp how the tech works in practice.
25,230 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Robinhood has evolved from a simple trading app to a platform with broader fintech ambitions. This article explores p...
A director sold 2,700 Wingstop shares, sparking questions about the stock's outlook. This guide breaks down what insi...
A major air campaign demonstrated how layered airpower blends stealth, electronic warfare, and precision munitions. I...
Lucid Group shares fell about 6% as investors grilled the company after a mixed Investor Day, with widening losses an...
A prominent chart analyst points to a long-term XRP pattern suggesting a dramatic upside in the next market cycle. Tr...
A shift from textbooks to screens and AI in classrooms coincides with a decline in america’s math scores. Experts war...
Unlock a practical, step-by-step blueprint for financial freedom through turnkey rentals. Learn how to estimate cash ...
Tower Semiconductor stock jumped today after a strategic move into AI networking. This article breaks down the deal, ...
A 34% jump in urea prices amid Iran tensions is sending shockwaves beyond farming. This article breaks down how ferti...
PI traders faced renewed selling pressure this week, driving PI below key thresholds. The market now tests 0.15 suppo...
The Fed’s decision to hold rates steady sent ripples through the market as inflation worries resurfaced. Here’s what ...